SpineGuard announced the grant of a new patent in Brazil, after its grant in other major geographies of the Spine Surgery sector. This patent closes certain characteristics of the DSG technology, indispensable to its real time implementation, and is valid until 2036.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1996 EUR | +5.61% | +1.53% | 0.00% |
04-17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.62M | |
+75.69% | 12.57B | |
-29.60% | 6.98B | |
-0.69% | 6.69B | |
+9.17% | 5.18B | |
+15.44% | 4.18B | |
-24.26% | 3.81B | |
-22.69% | 2.8B | |
-1.49% | 2B | |
+16.21% | 1.84B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard Strengthens its Intellectual Property with a New Patent Granted in Brazil